Isoflavones Market Report 2025

The isoflavones market size has grown rapidly in recent years. It will grow from $23.66 billion in 2024 to $26.49 billion in 2025 at a compound annual growth rate (CAGR) of 11.9%. The growth in the historic period can be attributed to increased health consciousness, growing demand for nutraceuticals, preventive healthcare trends, rising incidence of hormonal disorders, and expanding applications in food and beverages.

The isoflavones market size is expected to see rapid growth in the next few years. It will grow to $42.38 billion in 2029 at a compound annual growth rate (CAGR) of 12.5%. The growth in the forecast period can be attributed to research on menopausal symptom relief, expanding cosmetic and skin care applications, increased adoption of functional beverages, and growing awareness of plant-based diets. Major trends in the forecast period include emphasis on non-GMO and organic sources, focus on sports nutrition and performance, innovation in delivery formats, integration in plant-based protein products, and global market expansion.

The isoflavones market is poised for growth, driven by the rising utilization of isoflavones in the cosmetics sector. The cosmetics industry, encompassing the production and distribution of skincare products, has witnessed a surge in the incorporation of isoflavones, specifically aglycones and daidzein. These compounds offer antioxidant, anti-aging, soothing, and moisturizing properties. Notably, in 2023, the Cosmetic Toiletry & Perfumery Association (CTPA) reported an increase in the share of color cosmetics from 10.9% in 2021 to 11.3% in 2022, while the share of fragrances rose from 20.1% to 20.6%. This substantiates the growing significance of isoflavones in the cosmetics industry.

The growing geriatric population is anticipated to drive the expansion of the isoflavones market in the future. The geriatric population refers to elderly individuals, typically aged 65 and older, who have unique health considerations and care requirements. The isoflavones market is essential in addressing the needs of the aging population by offering innovative products with potential health benefits that enhance the overall well-being of older individuals. For example, in July 2024, data from the UK Parliament's House of Commons Library indicated that in 2022, approximately 12.7 million people in the UK were aged 65 or above, making up 19% of the population. This figure is projected to grow to 22.1 million by 2072, representing 27% of the total population. Thus, the increasing geriatric population is fueling the growth of the isoflavones market.

A prominent trend in the isoflavones market is the increasing emphasis on product innovations, a strategy gaining traction among major industry players. Leading companies within the isoflavones market are actively introducing novel products containing isoflavones to strengthen their market positions. An illustrative example is PharmaLinea, a Slovenia-based manufacturer of food supplements, which, in October 2022, launched Meno Ease Capsules. This advanced menopause supplement incorporates soy isoflavones for relieving menopausal symptoms, featuring an upgraded version developed by the renowned Matevz Ambrozic.

Major players in the isoflavones market are strategically focusing on product launches, particularly in the realm of plant-based product series, to capitalize on the growing demand for isoflavones across diverse industries. A plant-based product series comprises items derived exclusively from plant sources, excluding any animal-derived ingredients. A case in point is Otsuka Pharmaceutical Co., Ltd. (OPC), a Japan-based pharmaceutical company. In February 2022, OPC introduced The SOYJOY Plant-Based series, composed of 100% plant-based ingredients, prominently featuring soy as a rich source of isoflavones and other nutritional elements. This product launch signifies a deliberate shift towards plant-based offerings, expanding the existing SOYJOY line with Vegan certification, new flavors, and a heightened focus on health and wellness. Otsuka's strategic move is anticipated to have a significant impact on the isoflavones market by addressing the increasing demand for diverse plant-based products and promoting the associated health benefits of isoflavones.

In August 2022, The Archer-Daniels-Midland Company, a prominent US-based manufacturer of isoflavones, formed a partnership with Benson Hill Inc., a food manufacturing company in the US, for an undisclosed sum. This collaboration is geared towards establishing comprehensive seed-to-fork capabilities through advanced technologies. The goal is to provide pioneering products to their clientele in the alternative protein sector.

Major companies operating in the isoflavones market include Cargill Incorporated, The Archer-Daniels-Midland Company, BASF SE, International Flavors & Fragrances Inc., Koninklijke DSM N.V., Otsuka Pharmaceutical Co. Ltd., Novozymes A/S, Naturex SA, Fujicco Co. Ltd., NOW Foods Private Limited, Guilin Layn Natural Ingredients Corp., Nexira Inc., Changsha Huir Biological-Tech Co. Ltd., Bio-gen Extracts Private Limited, Hunan Huacheng Biotech Inc., Organic Herb Inc., NutraScience Labs, Wuhan HengHeDa Pharm Co. Ltd., Hunan Sunfull Bio-tech Co. Ltd., Sikko Industries Ltd., Xi'an Greena Biotech Co. Ltd., Hunan Nutramax Inc., Shaanxi Pioneer Biotech Co. Ltd., Changsha Natureway Co. Ltd., Xi'an Sgonek Biological Technology Co. Ltd.

North America was the largest region in the isoflavones market in 2024. The regions covered in the isoflavones market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the isoflavones market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

Isoflavones are naturally occurring organic compounds that belong to the flavonoid family. They are predominantly found in a variety of plant sources, especially in legumes like fava beans, pistachios, as well as other fruits and nuts. Their chemical structure resembles that of estrogen, a hormone present in the human body. Isoflavones are recognized for their potential health benefits, which include reducing the risk of specific cancers, enhancing heart health, and alleviating menopausal symptoms due to their estrogen-like effects.

The primary sources of isoflavones encompass soybeans, peanuts, chickpeas, clover, among others. Soybeans, a widely cultivated legume for their edible seeds, are available in organic and conventional variants, presented in forms such as powder and liquid. Their applications span across food and beverages, nutraceuticals, cosmetics, and various other sectors.

The isoflavones market research report is one of a series of new reports that provides isoflavones market statistics, including isoflavones industry global market size, regional shares, competitors with an isoflavones market share, detailed isoflavones market segments, market trends, and opportunities, and any further data you may need to thrive in the isoflavones industry. This isoflavones market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The isoflavones market consists of sales of fortified isoflavone, isoflavone concentrate, and isoflavone extracts. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.